Results 191 to 200 of about 76,948 (211)

Functional assessment of the effects of CYP3A4 variants on acalabrutinib metabolism in vitro

Chemico-Biological Interactions, 2021
Jianchang Qian, Zhize Ye, Jian-Ping Cai   +2 more
exaly  

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

European Journal of Clinical Pharmacology, 2004
Chin B Eap, Thierry Buclin, P Baumann
exaly  

The barrier function of CYP3A4 and P-glycoprotein in the small bowel

Advanced Drug Delivery Reviews, 1997
Paul B Watkins
exaly  

Potent mechanism‐based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates

British Journal of Pharmacology, 2012
Anne M Filppula, Pertti J Neuvonen, Janne T Backman   +2 more
exaly  

CYP3A4*22: Promising Newly IdentifiedCYP3A4Variant Allele for Personalizing Pharmacotherapy

Pharmacogenomics, 2013
Laure Elens, Teun Van Gelder, Dennis A Hesselink   +2 more
exaly  

CYP3A4Intron 6 C>T SNP (CYP3A4*22) Encodes Lower CYP3A4 Activity in Cancer Patients, as Measured with Probes Midazolam and Erythromycin

Pharmacogenomics, 2013
Laure Elens, Stephen Clarke, Kellie A Charles   +2 more
exaly  

CYP3A4 Polymorphisms--Potential Risk Factors for Breast and Prostate Cancer: A HuGE Review

American Journal of Epidemiology, 2004
Channa Keshava, Ainsley Weston
exaly  

The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells

Biochemical Pharmacology, 2011
Michael Török, Stephan KrähenbüHl
exaly  

Evaluation of EROD and CYP3A4 activities in earthworm Eisenia fetida as biomarkers for soil heavy metal contamination

Journal of Hazardous Materials, 2012
Xiufeng Cao, Yufang Song, Xiaoxia Yang   +2 more
exaly  

Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues

International Journal of Cancer, 2002
Yasuo Miyoshi, Tetsuya Taguchi
exaly